“Dr. Saphier would be a catastrophic mistake on messaging and communicating with MAHA at a time where the coalition is very fragile,” one opponent says.
The Erlangen, Germany-based device manufacturer announced its quarterly earnings results on May 7, which included a 6.5% year-over-year decline in revenue for its diagnostics segment.
First approved by the FDA in 2021, providers have rapidly adopted this clinical innovation, which offers greater accuracy in detecting prostate cancer.
Reports indicate the doctor frequently changed orders and completed alternate exams or procedures without providing clinical documentation to justify the changes.
Although large language models produce appeals letters that are generally deemed useful by readers, they likely still require a babysitter, according to a new analysis.
The California Franchise Tax Board had charged that the rad and his sole proprietorship could be combined to constitute a "unitary business," subject to state taxation.
The Scottsdale, Arizona-based radiology practice said Monday it’s seeking to scale AI across all routine imaging, hoping to deliver “preventive insights nationwide.”
Thanks to AI, clinicians can use mammograms to do a lot more than identify signs of breast cancer. Researchers explored data from nearly 50,000 patients, presenting their findings in Heart.
A new analysis is prompting questions regarding how rigorously many of the AI-enabled tools approved by the U.S. Food and Drug Administration are evaluated prior to their clearance.
